See also this year's filing and all EDGAR filings for this company.
PDF Report 0001107421_2022_Alaunos_Therapeutics_Inc.pdf
Logs
Graph
Absolute values for 0001107421, Alaunos Therapeutics Inc.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 78,831,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 10,941,000 |
| 3 | remainder_Assets | 5,093,000 |
| 4 | LiabilitiesCurrent | 16,041,000 |
| 5 | LiabilitiesNoncurrent | 16,250,000 |
| 6 | remainder_Liabilities | 4,518,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 27,564,000 |
| 9 | ResearchAndDevelopmentExpense | 49,643,000 |
| 10 | remainder_Expenses | 740,000 |
| 11 | remainder_Revenues | 398,000 |
| 12 | remainder_NetIncome | -1,202,000 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 94,865,000 |
| 1 | Liabilities | 36,809,000 |
| 2 | Expenses | 77,947,000 |
| 3 | Revenues | 398,000 |
| 4 | StockholdersEquity | 58,056,000 |
| 5 | NetIncome | -78,751,000 |
| 6 | ComprehensiveNetIncome | -78,751,000 |
| 7 | BaseVar | 105,610,500 |
| 8 | EconomicCapitalRatio | 0.321 |
Edgar->Model Mapping
Feature Distribution
Change over Time
